10/06/2026
Danielle, President of Friends of the PBC Foundation, will be speaking tomorrow at the World Orphan Drug Congress.
๐Boston, MA
Hall C : Track 1 - Rare Advocacy
๐๏ธ Tomorrow, June 11
โฐ2:00-2:40 pm EST
Here is what she had to say, "See me tomorrow at World Orphan Drug Congress speaking about clinical trial regulations and the unethical challenges faced by patients living with primary biliary cholangitis. This is a very important topic to me since being the FDA PBC Patient Representative on the GIDAC committee regarding Ocaliva in September 2024. It is time for regulators to put the patient's lived experience first when it comes to regulatory data and standards. I will be speaking about the work that has come out of the International PBC Summit that the PBC Foundation, Friends of the PBC Foundation, and the PBC community as a whole across the globe have been working on for the last several years. It's clear that patients, patient advocacy groups, clinicians, biostatisticians, the pharmaceutical industry and all stakeholders in this community want an end to long-term placebo trials when it comes to PBC. Let's work together to make changes for the better in the rare disease community. Thank you Rare Disease Advisor for giving me this platform and an opportunity to be heard."